Titan Pharmaceuticals Inc (TTNP): Shortanalylics.com Data Analysis-TTNP B...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Titan Pharmaceuticals Inc (TTNP)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	133
Posts	24518
Boards Moderated	2
Alias Born	03/03/2013

Re: None

Thursday, 08/25/2016 9:52:36 AM

Thursday, August 25, 2016 9:52:36 AM

Shortanalylics.com Data Analysis-TTNP
Built For Traders By Traders

Data Analysis-TTNP

Date Symbol Name Short Volume Long Volume Total Volume Short%
2016-08-24 TTNP Titan Pharma Cmn 91236 54667 145903 63
2016-08-23 TTNP Titan Pharma Cmn 50678 33802 84480 60
2016-08-22 TTNP Titan Pharma Cmn 79657 75842 155499 51
2016-08-19 TTNP Titan Pharma Cmn 33379 10302 43681 76
2016-08-18 TTNP Titan Pharma Cmn 37737 37101 74838 50
2016-08-17 TTNP Titan Pharma Cmn 17819 16363 34182 52
2016-08-16 TTNP Titan Pharma Cmn 22834 43135 65969 35
2016-08-15 TTNP Titan Pharma Cmn 89283 70671 159954 56
2016-08-12 TTNP Titan Pharma Cmn 62101 40826 102927 60
2016-08-11 TTNP Titan Pharma Cmn 43402 29926 73328 59
2016-08-10 TTNP Titan Pharma Cmn 88259 50949 139208 63
2016-08-09 TTNP Titan Pharma Cmn 43369 66967 110336 39
2016-08-08 TTNP Titan Pharma Cmn 31903 45035 76938 41
2016-08-05 TTNP Titan Pharma Cmn 31041 25034 56075 55
2016-08-04 TTNP Titan Pharma Cmn 45225 25632 70857 64
2016-08-03 TTNP Titan Pharma Cmn 11259 12336 23595 48
2016-08-02 TTNP Titan Pharma Cmn 49284 34761 84045 59
2016-08-01 TTNP Titan Pharma Cmn 19211 43232 62443 31

Blessings to All

TRUTH

I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TTNP News

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/21/2024 12:32:38 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/19/2024 08:23:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:22:56 PM
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. • GlobeNewswire Inc. • 08/19/2024 08:11:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2024 01:29:55 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 01:29:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:33:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:31:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:29:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:25:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:23:37 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/24/2023 09:26:34 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:08:35 PM
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors • GlobeNewswire Inc. • 10/16/2023 08:37:23 PM
Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/04/2023 09:30:18 PM

More TTNP News

InvestorsHub NewsWire

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow